- Home
- ZTS vs NTES Comparison
ZTS vs NTES Comparison
Compare ZTS & NTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTS
- NTES
- Stock Information
- Founded
- ZTS 1952
- NTES 1997
- Country
- ZTS United States
- NTES China
- Employees
- ZTS N/A
- NTES N/A
- Industry
- ZTS Biotechnology: Pharmaceutical Preparations
- NTES Computer Software: Prepackaged Software
- Sector
- ZTS Health Care
- NTES Technology
- Exchange
- ZTS Nasdaq
- NTES Nasdaq
- Market Cap
- ZTS 73.2B
- NTES 78.0B
- IPO Year
- ZTS 2013
- NTES 2000
- Fundamental
- Price
- ZTS $155.44
- NTES $134.64
- Analyst Decision
- ZTS Buy
- NTES Strong Buy
- Analyst Count
- ZTS 8
- NTES 7
- Target Price
- ZTS $211.50
- NTES $117.86
- AVG Volume (30 Days)
- ZTS 3.1M
- NTES 968.8K
- Earning Date
- ZTS 08-05-2025
- NTES 08-21-2025
- Dividend Yield
- ZTS 1.28%
- NTES 2.08%
- EPS Growth
- ZTS 7.32
- NTES 7.67
- EPS
- ZTS 5.57
- NTES 1.38
- Revenue
- ZTS $9,286,000,000.00
- NTES $14,782,889,829.00
- Revenue This Year
- ZTS $3.54
- NTES $11.09
- Revenue Next Year
- ZTS $6.11
- NTES $6.92
- P/E Ratio
- ZTS $28.04
- NTES $18.80
- Revenue Growth
- ZTS 6.32
- NTES 1.90
- 52 Week Low
- ZTS $139.70
- NTES $75.85
- 52 Week High
- ZTS $200.33
- NTES $134.12
- Technical
- Relative Strength Index (RSI)
- ZTS 39.75
- NTES 65.64
- Support Level
- ZTS $154.26
- NTES $127.59
- Resistance Level
- ZTS $158.70
- NTES $134.12
- Average True Range (ATR)
- ZTS 3.47
- NTES 1.64
- MACD
- ZTS -1.28
- NTES -0.41
- Stochastic Oscillator
- ZTS 12.20
- NTES 86.81
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
About NTES NetEase Inc.
Founded in the late 1990s as an internet portal, NetEase has transformed into a leading force in the second-largest online game company gaming in China. While its initial success was built upon the massively multiplayer online role-playing game Fantasy Westward Journey, NetEase has expanded its portfolio with captivating franchises that resonate with both domestic and international players. Over the past decade, the company has created titles such as Justice, Identity V, Naraka: Bladepoint, and Eggy Party, all of which maintain significant player bases today. Beyond in-house development, the company also collaborates with likes of Microsoft and Marvel to create and publish games based on renowned IPs, including World of Warcraft, Diablo Immortal, and Marvel Rivals.